Author:
Lingling Wang,Guixin Chen,Wei Li,Hua Sun
Abstract
Objective:The objective of this study is to analyze the interaction between the urinary 11-dehydrothromboxane B2 (11-DH-TXB2) content and the smoking, drinking, hypertension or diabetes history of patients with cerebral infarction, and to determine the value of 11-DH-TXB2 in the occurrence and prevention of cerebral infarction.Methods:117 patients with cerebral infarction and 50 healthy controls were selected. Their general information, including smoking, drinking, hypertension and diabetes history, was analyzed, and their urinary11-DH-TXB2 contents were measured. The difference in the urinary 11-DH-TXB2 content between the two groups, and the additive model of the interaction between the urinary 11-DH-TXB2 content and other risk factors of cerebrovascular diseases were statistically analyzed.Results:There was no significant difference in the general information between the two groups (P> 0.05). Significant differences were observed in the urinary 11-DH-TXB2 content, and the smoking, diabetes and hypertension history between the two groups, while there was no significant difference in the drinking history between the two groups. The analysis of the interaction additive model showed that the OR value was 1, the synergy index (S) of increased 11-DH-TXB2 and smoking history was 1.219, the S of increased 11-DHTXB2 and hypertension history was 5.578 and that of increased 11-DH-TXB2 and the diabetes history was 4.604.Conclusion:There is a correlation between the urinary 11-DH-TXB2 content and the occurrence of cerebral infarction, and there is a synergistic interaction between the urinary DH-TXB2 content and the smoking, hypertension or diabetes history of patients with cerebral infarction. The increased 11-DH-TXB2 may be a risk factor for cerebral infarction and the urinary 11-DHTXB2 content can be used as an index to predict the occurrence and progression of cerebral infarction.
Publisher
Bentham Science Publishers Ltd.
Subject
General Materials Science
Reference19 articles.
1. Wang L, Liu J, Ying Y, et al. Report on stroke prevention and treatment in China 2017 outline. Chin J Cerebrovasc Dis 2018; 15 (11) : 611-6.
2. Chen J. Role of platelets in the formation and development of atherosclerosis. Chin Circ J 2004; 19 : 5-6.
3. Huang JS, Ramamurthy SK, Lin X, Le Breton GC. Cell signalling through thromboxane A2 receptors. Cell Signal 2004; 16 (5) : 521-33.
4. Zhong W, Hu Y. Experimental study on atherosclerosisII: Effects of Chinese medicine 850 on the balance of thromboxane A2 and prostaglandin in rabbits with experimental atherosclerosis. Acta Academiae Medicinae Sinicae 1988; 10 (6) : 421-5.
5. Borg C, Lim CT, Yeomans DC, et al. Purification of rat brain, rabbit aorta, and human platelet thromboxane A2/prostaglandin H2 receptors by immunoaffinity chromatography employing anti-peptide and anti-receptor antibodies. J Biol Chem 1994; 269 (8) : 6109-16.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献